Bias reduction for risk ratio and vaccine effect estimators

Statistics in Medicine

Volumn 20, Issue 11, 2001, Pages 1609-1624

  Chick, Stephen E ^a   Barth Jones, Daniel C ^b   Koopman, James S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MALARIA VACCINE; ORAL POLIOMYELITIS VACCINE; PLACEBO; VACCINE;

ANALYTICAL ERROR; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFECT; INFECTION; INFECTION SENSITIVITY; MATHEMATICAL COMPUTING; RISK ASSESSMENT; SIMULATION;

BAYES THEOREM; BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; RISK; VACCINATION; VACCINES;

EID: 0035875886     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.788     Document Type: Article

References (31)

1. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies
2. Estimation of vaccine efficacy in outbreaks of infectious diseases
3. Assessing contagiousness effects of vaccines and risk factors for transmission
4. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations
5. Estimation of vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines with partner augmentation
6. Assessing HIV vaccine effects
7. Viral load and heterosexual transmission of human immunodeficiency virus type 1
8. The estimation of the basic reproduction number for infectious diseases
9. Simulations to evaluate HIV vaccine trial methods
10. The effect of response bias on the odds ratio
11. Bias in indirectly adjusted comparisons due to taking the total study population as the reference group
12. Maximum likelihood estimators for incorrect models, with an application to ascertainment bias for continuous characters
13. The correlation structure of epidemic models
14. Some important issues in the planning of phase III HIV vaccine efficacy trials
15. Quantifying misclassification bias in cohort studies of vaccine efficacy
16. Intermediate-size trials for the evaluation of HIV vaccine candidates: A workshop summary
17. Initial clinical evaluation of new vaccine candidates: Phase 1 and 2 clinical trials of safety, immunogenicity, and preliminary efficacy
18. On the bias of commonly used measures of association for 2x2 tables
19. Urn models and vaccine efficacy estimation
20. The retrospective partner trials (RPT) HIV vaccine study design for the measurement of vaccine effects on susceptibility and infectiousness
21. Biostatistics and Bayes
22. Simple Bayesian analysis for case-control studies in cancer epidemiology
23. Low-efficacy HIV vaccines: Potential for community-based intervention programmes
24. Comparing methods for calculating confidence intervals for vaccine efficacy
25. Causal inference for infectious diseases
26. The detection of defective members of a large population
27. Bayesian models for limiting dilution assay and group test data